Depressive Disorder, Major trials recruiting in Connecticut

All Depressive Disorder, Major trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• A Study of Brenipatide in Adult Participants With Major Depressive Disorder
  NCT07412756 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Connecticut: New Haven
• Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
  NCT05915013 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Connecticut: New Haven
• Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
  NCT06559306 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Connecticut: Farmington